search
Back to results

HIV Reengagement and Assessment Mobile Program (Project RAMP)

Primary Purpose

HIV/AIDS

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Reengagement and Assessment Mobile Program
Qualitative Interview
Sponsored by
University of North Carolina, Chapel Hill
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for HIV/AIDS

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age >= 18 years
  • HIV positive
  • Referred to the bridge counselors by the partnering clinic as out of care for >=6 months and not successfully re-engaged in care by a bridge counselor
  • Willing and able to give informed consent and adhere to study visits

Exclusion Criteria:

  • Unwilling or physically unable to participate in study visits on the mobile van
  • Lack of English language fluency
  • Planning or preferring to transfer HIV care to an HIV clinic other than the partnering HIV clinic
  • Pregnant women will be expedited into clinical care and will not be eligible for the study
  • Presence of mobility or balance issues that prevent patient from safely stepping up onto the mobile unit without assistance

Sites / Locations

  • University of North Carolina at Chapel Hill

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Other

No Intervention

Arm Label

Intervention Group

Usual Care Reengagement Group

Non-enrolling Group

Arm Description

This group will complete an HIV health reengagement intervention on a mobile van, in addition to a pre- and post-intervention qualitative interview.

This group will complete a qualitative interview about barriers and facilitators to HIV care.

This group will not be enrolled in the intervention, and will include de-identified data from clinic patients referred to bridge counselors during the study time period that do not participate in the intervention.

Outcomes

Primary Outcome Measures

Percentage of eligible persons screened that enroll.
Percentage of all eligible persons that are screened by the study team that enroll in Project RAMP during the intervention period.
Qualitative Summary of Participants' Experiences from In-depth Baseline Interview
Data will be obtained from in-depth qualitative interviews. Summary will include reasons why patients who have been out of care for more than 6 months have been lost to care.
Qualitative Summary of Participants' Experiences from In-depth Exit Interview
Data will be obtained from in-depth qualitative interviews. Summary will include information evaluating participants' experiences in Project RAMP.

Secondary Outcome Measures

Number of participants who are successfully reengaged following the intervention.
Reengagement is defined as 1 kept visit following the intervention. The investigators will collect this data from the participants' medical record.
Number of participants who are successfully retained following the intervention.
Retention is defined as 2 kept visits following the intervention. The investigators will collect this data from the participant's medical record.
Number of participants who have viral suppression following the intervention.
Viral suppression is defined as <200 copies/mL. The investigators will collect data on viral suppression from participant's medical record.

Full Information

First Posted
October 23, 2019
Last Updated
June 14, 2023
Sponsor
University of North Carolina, Chapel Hill
Collaborators
ViiV Healthcare
search

1. Study Identification

Unique Protocol Identification Number
NCT04151498
Brief Title
HIV Reengagement and Assessment Mobile Program (Project RAMP)
Official Title
Project RAMP (Reengagement and Assessment Mobile Program): A Field Visit Model for HIV Clinic Reengagement
Study Type
Interventional

2. Study Status

Record Verification Date
June 2023
Overall Recruitment Status
Completed
Study Start Date
May 29, 2020 (Actual)
Primary Completion Date
November 12, 2022 (Actual)
Study Completion Date
April 28, 2023 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of North Carolina, Chapel Hill
Collaborators
ViiV Healthcare

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The North Carolina Bridge Counselor system is designed to help link out of care HIV positive patients back into HIV care. It has improved initial linkages and patient re-engagement overall, but for a sizable group of patients, the current system has not been effective, leaving a population of hard-to-reach, lost-to-care patients who remain out of care. There is limited understanding of the lived experiences of patients who fall out of HIV care and become recalcitrant to re-engagement because they are difficult to reach and therefore underrepresented in research. Out of care HIV+ patients who have not reengaged in care following the standard of care who chose to enroll in the study will participate in 2 semi-structured interviews and receive a field-based HIV re-engagement and treatment intervention (Project RAMP). Project RAMP will consist of up to 4 visits from an outreach research nurse designed to serve as an "on-ramp" to HIV care. At these visits, the outreach number will counsel on HIV care and treatment and obtain a medical history and labs. Results will be communicated to the participant's clinic provider in an effort to both encourage the patient to return to care and facilitate more rapid antiretroviral therapy (ART) initiation by the clinic provider. The research team will also provide the participant in-person assistance with scheduling a clinic visit. Clinic providers may re-initiate ART prior to the reengagement clinic visit, with adherence support provided by the outreach nurse.
Detailed Description
The overall purpose of the Project RAMP intervention is to find out what challenges make it hard for people living with HIV to keep their in-person clinic appointments. The investigators also hope to learn how much a mobile HIV treatment van may help patients who have been out of care for a minimum of 6 months, to re-start keeping regular clinic visits. The investigators also hope this information will help be useful in learning best practices for providing health care to people living with HIV. This study will recruit a total of 30 participants, 20 for the intervention and 10 for the usual care group. Participants will be recruited through bridge counselors at the partnering clinic, whose roles and responsibilities consist of finding and reaching out to patients who have been out of HIV care in an attempt to get them reengaged. Participants will have up to 5 study visits that are between 1- 4 weeks apart. Each visit will last about 1 to 1.5 hours. Participants will also be asked to participate in two in depth interview: a baseline interview at the start of the study that will ask questions about each participant's experience with their past clinic visits and an exit interview at the end of the study regarding their experience participating in the HIV mobile treatment program (Project RAMP). The pre-intervention visit (Visit 0) includes the first interview, providing some brief information about you, a urine pregnancy test for participants who are female, and a brief meeting with a financial technician who will help participants complete their insurance information. Intervention Visit 1 will include a nurse from the partnering clinic administering the video educational intervention, HIV medication adherence counseling, a health history form, blood draws for standard reengagement labs (CD4 count, HIV viral load, comprehensive metabolic panel, complete blood count with differential, rapid plasma reagin and HIV genotype). Specimens from these visits will be delivered to partnering clinic for analysis. Notes from the mobile visit will be shared with the study PI, who will in term communicate these notes with the assigned clinic provider of each participant. Visits 2-4 will include a study nurse conducting additional blood draws if recommended by their assigned provider, and a review of adherence counseling and health history forms. At the end of each intervention visit, participants will be if they would like to make an in person clinic appointment. Those who decline at the end of intervention Visits 1-3 will be offered an additional field visit appointment. Those who decline an in person clinic appointment at the end of Visit 4 will move on to completing the exit interview in person at this time and will complete the study following the exit interview. Participants who schedule a clinic appointment will have their exit interview in person or via phone within 3 months of their clinic visit. All participants will be follow up to 6 months after their last study visit to to access their viral load, if this information is available.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
HIV/AIDS

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
30 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Intervention Group
Arm Type
Experimental
Arm Description
This group will complete an HIV health reengagement intervention on a mobile van, in addition to a pre- and post-intervention qualitative interview.
Arm Title
Usual Care Reengagement Group
Arm Type
Other
Arm Description
This group will complete a qualitative interview about barriers and facilitators to HIV care.
Arm Title
Non-enrolling Group
Arm Type
No Intervention
Arm Description
This group will not be enrolled in the intervention, and will include de-identified data from clinic patients referred to bridge counselors during the study time period that do not participate in the intervention.
Intervention Type
Behavioral
Intervention Name(s)
Reengagement and Assessment Mobile Program
Other Intervention Name(s)
Project RAMP
Intervention Description
Participants will participate in mobile clinic visit that will include an educational interview, adherence counseling, and standard blood draws for HIV reengagement. The goal of this intervention is to motivate participants to become reengaged in traditional HIV care by making an in person clinic appointment.
Intervention Type
Other
Intervention Name(s)
Qualitative Interview
Intervention Description
Qualitative interview about barriers and facilitators to HIV care, and experience at most recent clinic visit.
Primary Outcome Measure Information:
Title
Percentage of eligible persons screened that enroll.
Description
Percentage of all eligible persons that are screened by the study team that enroll in Project RAMP during the intervention period.
Time Frame
Screening call through Visit 0 when consent occurs, approximately 2 - 3 weeks
Title
Qualitative Summary of Participants' Experiences from In-depth Baseline Interview
Description
Data will be obtained from in-depth qualitative interviews. Summary will include reasons why patients who have been out of care for more than 6 months have been lost to care.
Time Frame
Up to approximately 1 hour at Baseline
Title
Qualitative Summary of Participants' Experiences from In-depth Exit Interview
Description
Data will be obtained from in-depth qualitative interviews. Summary will include information evaluating participants' experiences in Project RAMP.
Time Frame
Up to approximately 1 hour at Exit Interview
Secondary Outcome Measure Information:
Title
Number of participants who are successfully reengaged following the intervention.
Description
Reengagement is defined as 1 kept visit following the intervention. The investigators will collect this data from the participants' medical record.
Time Frame
6 months following the participants' last intervention visit
Title
Number of participants who are successfully retained following the intervention.
Description
Retention is defined as 2 kept visits following the intervention. The investigators will collect this data from the participant's medical record.
Time Frame
6 months following the participants' last intervention visit
Title
Number of participants who have viral suppression following the intervention.
Description
Viral suppression is defined as <200 copies/mL. The investigators will collect data on viral suppression from participant's medical record.
Time Frame
6 months following participants' last intervention visit

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age >= 18 years HIV positive Referred to the bridge counselors by the partnering clinic as out of care for >=6 months and not successfully re-engaged in care by a bridge counselor Willing and able to give informed consent and adhere to study visits Exclusion Criteria: Unwilling or physically unable to participate in study visits on the mobile van Lack of English language fluency Planning or preferring to transfer HIV care to an HIV clinic other than the partnering HIV clinic Pregnant women will be expedited into clinical care and will not be eligible for the study Presence of mobility or balance issues that prevent patient from safely stepping up onto the mobile unit without assistance
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Christopher Sellers, MD
Organizational Affiliation
University of North Carolina, Chapel Hill
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of North Carolina at Chapel Hill
City
Chapel Hill
State/Province
North Carolina
ZIP/Postal Code
27514
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Participant data will be shared after publication.
IPD Sharing Time Frame
9 to 36 months following publication.
IPD Sharing Access Criteria
Deidentified individual data that supports the results will be shared provided the investigator who proposes to use the data has approval from an Institutional Review Board (IRB), Independent Ethics Committee (IEC), or Research Ethics Board (REB), as applicable, and executes a data use/sharing agreement with the University of North Carolina at Chapel Hill.

Learn more about this trial

HIV Reengagement and Assessment Mobile Program (Project RAMP)

We'll reach out to this number within 24 hrs